Calamos Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.03M Hold
371,532
– – 0.01% 583
2026
Q2
$3.97M Buy
+371,532
New +$3.97M 0.01% 582

Other funds holding TDAC

Calamos Advisors's TDAC Position: Q3 2026 in Review

Calamos Advisors held its Translational Development Acquisition Corp (TDAC) position steady in Q3 2026 at 371,532 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #583.

Calamos Advisors first reported a position in TDAC in Q2 2026 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold TDAC as of Q3 2026.

  • Calamos Advisors held 371,532 shares of Translational Development Acquisition Corp worth $4.03M as of Q3 2026.
  • Calamos Advisors left its Translational Development Acquisition Corp share count unchanged in Q3 2026.
  • Translational Development Acquisition Corp made up 0.01% of Calamos Advisors's portfolio in Q3 2026, its #583 holding.
  • Calamos Advisors first reported a position in Translational Development Acquisition Corp in Q2 2026 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.